Learn more about the ESCMID guidance documents, which aim to strengthen best practices in the diasnosis and treatment of infectious diseases. Published Guidelines · Guidelines & Journals · Guidelines in Development

Discover the summary of our 2021 - 2023 guidelines, along with other guidelines endorsed by ESCMID.

ESCMID guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)

16 дек. 2021 г. · These ESCMID guidelines address the targeted antibiotic treatment of third-generation cephalosporin-resistant Enterobacterales (3GCephRE) and carbapenem- ...

These ESCMID guidelines address the targeted antibiotic treatment of third-generation cephalosporin-resistant Enterobacterales (3GCephRE) and carbapenem- ...

ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized ...

These evidence-based guidelines have been produced after a systematic review of published studies on infection prevention and control interventions.

Previous ECMM/ESCMID Guidelines. ESCMID ECMM ERS Guidelines ... ESCMID ECMM Guidelines Rare and Emerging Fungal Infections 2013 (Methodology): ...

9 февр. 2022 г. · What is made clear in both the ESCMID guidelines and IDSA guidance is the remarkable paucity of head-to-head trials comparing therapies directed ...

Scope: These ESCMID guidelines address the targeted antibiotic treatment of third-generation cepha losporin-resistant Enterobacterales (3GCephRE) and ...